UPC · Universe Pharmaceuticals INC · Insider Trading
Trades by corporate insiders — officers, directors and holders of more than 10% of the shares — disclosed to the SEC on Forms 4 and 5. Form 3 supplies initial ownership rather than a trade; Form 4 must be filed within two business days of the trade.
| Date | Insider | Role | Type | Security | Shares |
|---|---|---|---|---|---|
| 2026-05-07 | Lai Gang |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Class A ordinary shares, par value US$0.00001 per share (Direct)
Represents a grant of ordinary shares under the Issuer's 2026 Equity Incentive Plan, in a transaction exempt under Rule 16b-3, in consideration for past services rendered by the Reporting Person. The grant is subject to the terms of an award agreement entered into by and between the Reporting Person and the Issuer, dated May 5, 2026. |
Class A ordinary shares, par value US$0.00001 per share
|
71,890 |
| 2026-05-07 | Lai Gang |
Director, Chief Executive Officer |
Award↑
Filing footnotes — Class B ordinary shares, par value US$0.00001 per share (Direct)
Represents a grant of ordinary shares under the Issuer's 2026 Equity Incentive Plan, in a transaction exempt under Rule 16b-3, in consideration for past services rendered by the Reporting Person. The grant is subject to the terms of an award agreement entered into by and between the Reporting Person and the Issuer, dated May 5, 2026. |
Class B ordinary shares, par value US$0.00001 per share
|
12,610 |